EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 47 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,090,400 | +1.8% | 504,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $5,000,000 | +1.3% | 504,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $4,934,000 | +0.5% | 504,000 | 0.0% | 0.01% | +50.0% |
| Q1 2022 | $4,909,000 | +0.5% | 504,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $4,884,000 | +0.2% | 504,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,874,000 | – | 504,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |